{"title":"Alpha2 adrenoceptor agonists in the horse—Areview","authors":"G.C.W. England, K.W. Clarke","doi":"10.1016/S0007-1935(96)80118-7","DOIUrl":"10.1016/S0007-1935(96)80118-7","url":null,"abstract":"<div><p>In recent years the usefulness of the alpha,, adrenoceptor agonist drugs has been recognized in equine practice. Several agents have become available and are now licensed for use in a number of countries. The principle actions of all alpha<sub>2</sub> adrenoceptor agonists are similar, in that they produce a reduction in heart rate and alteration of heart rhythm, an initial hypertension followed by a prolonged hypotension, a decrease in tile cardiac output and respiratory depression. For clinical purposes, these agents produce sedation and analgesia, they are useful for premedication and markedly potentiate the effects of other sedative/analgesic agents. Differences in receptor specificity between the alpha<sub>2</sub> adrenoceptor agonists results in the distinguishing characteristics of the individual agents, particularly with respect to their duration of action, sedative effect and analgesic properties; their cardiopulmonary effects are however similar, when equipotent sedative closes are administered. When used in combination with other agents, the alpha<sub>2</sub> adrenoceptor agonists all appear to act in a similar manner, with the greatest difference being related to their duration of action.</p></div>","PeriodicalId":100203,"journal":{"name":"British Veterinary Journal","volume":"152 6","pages":"Pages 641-657"},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0007-1935(96)80118-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19943000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Managing a Veterinary Practice, D.C. Jack (Ed.). W. B. Saunders, London (1994), ISBN: 0-9205-1311-5","authors":"D. Thompson","doi":"10.1016/S0007-1935(96)80126-6","DOIUrl":"https://doi.org/10.1016/S0007-1935(96)80126-6","url":null,"abstract":"","PeriodicalId":100203,"journal":{"name":"British Veterinary Journal","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88688934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Harriet W. Brooks, D.G. White, A.J. Wagstaff, A.R. Michell
{"title":"Evaluation of a nutritive oral rehydration solution for the treatment of calf diarrhoea","authors":"Harriet W. Brooks, D.G. White, A.J. Wagstaff, A.R. Michell","doi":"10.1016/S0007-1935(96)80123-0","DOIUrl":"10.1016/S0007-1935(96)80123-0","url":null,"abstract":"<div><p>The essential constituents of a conventional oral rehydration solution (ORS) are sodium, glucose and a bicarbonate precursor. The glucose promotes sodium uptake but because these solutions are isotonic, it is insufficient to sustain calorie requirements. This paper examines the performance of a novel ORS with over three times the conventional glucose concentration, by comparing it with two leading commercial ORSs in calves with induced <em>Escherichia coli</em> diarrhoea. This solution showed greater ability than the current market-leading ORS to repair extracellular fluid and plasma volume and to correct both hyponatraemia and metabolic acidosis, especially in more severely affected calves. In acidotic calves it was more effective in correcting hyperkalaemia, probably by supplying glucose to promote cellular potassium uptake as well as by correcting the acidosis. It therefore appears possible to depart from the traditional isotonic formulations for calf ORSs and gain significant nutritional support while retaining effective rehydration and correction of acid-base and electrolyte disturbances. This seems especially important in young animals where energy deprivation imposes a particular penalty; the use of hypertonic ORSs should not, however, be extended to other species without further research.</p></div>","PeriodicalId":100203,"journal":{"name":"British Veterinary Journal","volume":"152 6","pages":"Pages 699-708"},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0007-1935(96)80123-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19940945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A.J. Musoke , G.H. Palmer , T.F. McElwain , V. Nene , D. McKeever
{"title":"Prospects for subunit vaccines against tick borne diseases","authors":"A.J. Musoke , G.H. Palmer , T.F. McElwain , V. Nene , D. McKeever","doi":"10.1016/S0007-1935(96)80117-5","DOIUrl":"10.1016/S0007-1935(96)80117-5","url":null,"abstract":"<div><p>Tick-borne parasites are a serious impediment to the improvement of livestockproduction in the developing world. The major parasites affecting cattle include <em>Theileria parva, T. annulata, Babesia bigemina, B. bovis, Anaplasma marginale</em> and <em>Cowdria ruminantium</em>. The control of these infections is dependent on the use of acaricides to decrease transmission by the tick vectors, and immunization of susceptible animals with live vaccines. The use of acaricide is hampered by the development of resistance, and live vaccines require cold chain facilities, which are generally unreliable in developing countries. There is therefore a need for improved vaccines that can circumvent these problems. There is a subunit vaccine being developed for <em>T. parva</em> based on the major surface antigen of the sporozoite (p67). A similar antigen, SPAG 1, has been identified as a candidate for <em>T. annulata</em>. Although several candidate antigens have been identified for <em>Babesia</em> spp., progress towards development of a subunit vaccine based on these antigens has been hampered by polymorphism among isolates and between species, and lack of knowledge of the immune effector mechanisms responsible for protection. The search for protective antigens of <em>A. marginale</em> has focused on outer membrane proteins; immunization with a variety of these antigens alone or in combination, has yielded promising results. As with <em>Babesia</em>, further definition of immune effector mechanisms is needed to optimize immunization strategies. The work on identifying the protective antigens of <em>C. ruminantium</em> is in its embryonic stages; however, two antigens have been identified and are currently being evaluated. There is high expectancy for subunit vaccines for all these diseases; however there is need for further work to elucidate the immune mechanisms in order to select appropriate antigen delivery systems.</p></div>","PeriodicalId":100203,"journal":{"name":"British Veterinary Journal","volume":"152 6","pages":"Pages 621-639"},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0007-1935(96)80117-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19943001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
